Otros idiomas Turnstone Biologics Corp.

Acciones

TSBX

US90042W1009

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
2,62 ^USD	-12,37 %		-6,09 %	+2,95 %

13/05	Turnstone Biologics Corp. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
16/04	Turnstone Biologics Corp. anuncia cambios en el Consejo de Administración	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights	13/05
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference	08/05
Turnstone Biologics Appoints William Waddill to its Board of Directors	16/04
Turnstone Biologics Corp. Announces Board Changes	16/04
Turnstone Biologics Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	21/03
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	21/03
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	21/03
Turnstone Biologics to Participate in Upcoming Investor Conferences	21/02
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.	20/02
Turnstone Biologics Corp. Announces Demise of P. Joseph Campisi, Jr., Esq, Chief Legal Officer	20/02
Certain Common Stock of Turnstone Biologics Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2024.	17/01
Certain Stock Options of Turnstone Biologics Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2024.	17/01
Turnstone Biologics Falls 11% in Premarket Activity Tuesday After Surging 42% in Previous Regular Trading Session	05/12
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference	27/11
Turnstone Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights	10/11
Top Premarket Gainers	03/11
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	03/11
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	03/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Turnstone Biologics Corp.

Acciones

TSBX

US90042W1009

Otros idiomas

Filtros